With America’s scientists and researchers working around the clock to eradicate COVID-19, BIO President and CEO Jim Greenwood checked in with Dr. Jeremy Levin. Dr. Levin is CEO of Ovid Therapeutics and Chairman of BIO’s board of directors. In a recent edition of the I AM BIO podcast, Dr. Levin…

As countless people, companies, and organizations work together to combat the COVID-19 pandemic, one company is working to eradicate the virus itself at record speed. BIO CEO Jim Greenwood recently spoke with Stéphane Bancel, CEO of Moderna, which is racing to develop a vaccine to stop this deadly…

Many companies in the biotechnology industry are working to find new ways to combat the COVID-19 pandemic. On a recent I AM BIO podcast, BIO CEO Jim Greenwood sat down with Dr. George Yancopoulos, Regeneron’s President, Co-Founder, and Chief Scientific Officer, about how his team is responding and…

The biotech industry is working tirelessly to identify new advancements to diagnose, treat, and prevent COVID-19 and help save lives around the world. For a recent I AM BIO podcast, BIO CEO Jim Greenwood sat down with Dr. Julie Gerberding, Executive Vice President at Merck and former head of the…

We are living in unprecedented times, as cases of coronavirus (COVID-19) rapidly increase while the world struggles to contain the pandemic. The biotechnology industry has stepped up to help combat this public health threat, working tirelessly to develop potential treatments, diagnostics and…

As the novel coronavirus continues to spread, scientists and researchers are working around the clock to identify diagnostics, therapeutics and vaccines to help protect individuals and communities across the globe. This week, leaders within the biopharmaceutical industry took to the airwaves,…

“We will continue doing what we do best -- find new therapeutics to solve this crisis. Let’s all focus on this mission and not politics.” – Dr. Jeremy Levin, Biocentury Scientists and researchers at America’s biopharmaceutical companies are working around the clock to develop vaccines,…

The Personalized Medicine Coalition has released its annual report on precision medicine trends at the Food and Drug Administration (FDA). Their analysis covers FDA approvals in 2019, including new milestones in the continued pursuit of the precision medicine paradigm—the right drug for the patient…

Day #2 of the BIO CEO & Investor Conference was all about the future. How can we ensure the workforce reflects the diverse demographics of the patients the industry serves? What does the future of biotech investment look like? How can we incentivize innovation? Here are some takeaways from …

We’re seeing an “extraordinary level” of biotech innovation, said BIO Chair Jeremy Levin, CEO of Ovid Therapeutics Inc., while kicking off the 22nd BIO CEO & Investor Conference on February 10th in New York. Day #1 of the conference featured discussions about the breakthrough therapies of the…